PF-03382792

• Description :

  PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  433.52

• Molecular Formula :

  C23H32FN3O4

• Notes :

  Research use only, not for human use.

• Receptor :

  Other Targets

• CAS Number :

  1400811-63-3